Assembly Biosciences, Inc.
General ticker "ASMB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $124.7M (TTM average)
Assembly Biosciences, Inc. follows the US Stock Market performance with the rate: 57.5%.
Estimated limits based on current volatility of 3.4%: low 33.62$, high 35.97$
Factors to consider:
- Total employees count: 65 (-4.4%) as of 2023
- Top business risk factors: Dependence on pipeline success, Inability to raise capital, Geopolitical risks, Third-party risks, Labor/talent shortage/retention
- Current price 53.1% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.82$, 23.04$]
- 2025-12-31 to 2026-12-31 estimated range: [4.91$, 15.25$]
Financial Metrics affecting the ASMB estimates:
- Negative: with PPE of -2.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -56.12 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 18.93 < Shareholder equity ratio, % of 27.99 <= 41.86
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
Short-term ASMB quotes
Long-term ASMB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $7.16MM | $28.52MM |
| Operating Expenses | $94.11MM | $71.81MM | $73.94MM |
| Operating Income | $-94.11MM | $-64.65MM | $-45.42MM |
| Non-Operating Income | $1.02MM | $3.45MM | $5.57MM |
| R&D Expense | $69.98MM | $48.90MM | $55.93MM |
| Income(Loss) | $-93.09MM | $-61.20MM | $-39.85MM |
| Taxes | $0.00MM | $0.03MM | $0.33MM |
| Profit(Loss)* | $-93.09MM | $-61.23MM | $-40.18MM |
| Stockholders Equity | $82.66MM | $41.10MM | $33.36MM |
| Inventory | $0.00MM | $3.20MM | $0.00MM |
| Assets | $101.79MM | $136.82MM | $119.17MM |
| Operating Cash Flow | $-84.46MM | $22.74MM | $-51.12MM |
| Capital expenditure | $0.10MM | $0.26MM | $0.03MM |
| Investing Cash Flow | $90.64MM | $-69.14MM | $40.17MM |
| Financing Cash Flow | $0.61MM | $13.82MM | $29.45MM |
| Earnings Per Share** | $-23.08 | $-13.38 | $-6.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.